A retrospective study of the combination of apremilast with biologics in patients with psoriasis
Latest Information Update: 01 Jan 2021
At a glance
- Drugs Adalimumab (Primary) ; Apremilast (Primary) ; Infliximab (Primary) ; Ixekizumab (Primary) ; Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 01 Jan 2021 New trial record